AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Oct 2003 07:00 AM
RNS
Purchase of Own Securities
30 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
29 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
26 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
25 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
24 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
23 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
22 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
19 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
18 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
17 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
16 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
15 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
12 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
10 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
08 Sep 2003 04:00 PM
RNS
Director Shareholding
08 Sep 2003 07:00 AM
RNS
Symbicort
04 Sep 2003 05:15 PM
RNS
Director Shareholding
04 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
01 Sep 2003 07:54 AM
RNS
Exanta Study
01 Sep 2003 07:01 AM
RNS
Atacand CHARM Study
27 Aug 2003 03:00 PM
RNS
Capital Group
13 Aug 2003 07:01 AM
RNS
Crestor
08 Aug 2003 01:30 PM
RNS
Patent Infringement - Mylan
24 Jul 2003 11:00 AM
RNS
Interim Results - part 2 0f 2
24 Jul 2003 11:00 AM
RNS
Interim Results - part 1of 2
23 Jul 2003 09:00 AM
RNS
Notice of Results
14 Jul 2003 11:15 AM
RNS
Exanta
10 Jul 2003 07:00 AM
RNS
Crestor
08 Jul 2003 04:00 PM
RNS
Director Shareholding
01 Jul 2003 01:30 PM
RNS
New Appointments
23 Jun 2003 09:36 AM
RNS
Exanta
23 Jun 2003 07:37 AM
RNS
Statement re Zoladex
02 Jun 2003 07:00 AM
RNS
Purchase of Own Securities
30 May 2003 07:00 AM
RNS
Purchase of Own Securities
28 May 2003 07:00 AM
RNS
Purchase of Own Securities
22 May 2003 07:00 AM
RNS
Purchase of Own Securities
21 May 2003 07:00 AM
RNS
Purchase of Own Securities
20 May 2003 07:01 AM
RNS
Crestor
20 May 2003 07:00 AM
RNS
Purchase of Own Securities
19 May 2003 12:00 PM
RNS
Director Shareholding
19 May 2003 07:00 AM
RNS
Purchase of Own Securities
15 May 2003 12:00 PM
RNS
Director Shareholding
13 May 2003 07:00 AM
RNS
Purchase of Own Securities
08 May 2003 03:00 PM
RNS
Capital Group
08 May 2003 07:00 AM
RNS
Purchase of Own Securities
06 May 2003 04:00 PM
RNS
Capital Group
06 May 2003 07:00 AM
RNS
Iressa
02 May 2003 11:59 AM
RNS
AGM Resolutiions
30 Apr 2003 04:24 PM
RNS
AGM Poll Votes
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100

Latest directors dealings